Issue: January 2015
December 01, 2014
1 min read
Save

CHG-treated washcloths reduced S. aureus carriage in US jails

Issue: January 2015
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Distributing washcloths treated with a skin cleanser to jail detainees significantly reduced the carriage of Staphylococcus aureus, according to the results of a randomized controlled trial.

“Detainees in US jails are at high risk for skin infections caused by methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus,” study researcher Michael Z. David, MD, PhD, of the department of medicine at the University of Chicago, said in a press release. “While the use of [chlorhexidine gluconate (CHG)] has been well studied in the health care setting, there has been limited research for it in this high-risk population.”

In the study, 4,196 detainees in 68 detention divisions, or tanks, in the Dallas County Jail system were randomly assigned to one of three groups:

  • detainees who received disposable washcloths containing the skin cleanser CHG to clean their entire skin surface three times a week for 6 months
  • detainees who received identical washcloths containing only water
  • those who received no skin treatment

The researchers collected nares and hand cultures at baseline and at 2 and 6 months.

At baseline, S. aureus was isolated from 41.2% and MRSA from 8% of 947 detainees. At 6 months, the presence of MRSA in particular was not significantly reduced in either the control or intervention arms, but carriage of any type of S. aureus at that time was 51.1% in detainees who received no skin treatment, compared with 40.7% of those who used CHG-treated cloths (absolute risk reduction=10.4%; 95% CI, 0.01%-20.1%) and 42.8% of those assigned water-soaked cloths (absolute risk reduction=8.3%; 95% CI, –1.4% to 18%).

“Our findings suggest a promising and inexpensive intervention that may decrease S. aureus colonization in this high-risk group,” David said in the release.

Disclosure: David and another researcher report research funding from Sage Products.